Lupin Limited said that it has rolled out Lurasidone Hydrochloride Tablets in the strengths of 20mg, 40mg, 60mg, 80mg, and 120mg in the US. Lurasidone Hydrochloride Tablets is a generic version of Latuda Tablets of Sunovion Pharmaceuticals. Latuda Tablets is a daily once drug for adults and children, from 10 to 17 years, with bipolar […]
Lupin Limited has secured approval for its abbreviated new drug application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg from the United States Food and Drug Administration (FDA). The approved product of the Indian pharma company is a generic equivalent of Pfizer’s Toviaz Extended-Release Tablets, 4 mg and 8 mg, which is […]
Indian pharmaceutical company Lupin Limited has appointed Spiro Gavaris as president of its US generics business. Spiro Gavaris, who will be a part of the senior leadership team of the company, will handle the overall strategy, implementation, and expansion of the American generics business in the US. According to Lupin, Spiro Gavaris joins the company […]
Lupin Limited has announced the US launch of authorized generic version of Horizon Pharma Therapeutics’ PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w. Diclofenac Sodium Topical Solution is indicated for the treatment of arthritis of the knee. Citing data from IQVIA MAT October 2022, the Indian pharma company said that the estimated annual sales of Diclofenac […]
Indian pharma company Lupin Limited has launched Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial in the US market. The product is a generic version of Mylan Specialty’s Perforomist Inhalation Solution, 20 mcg/2 mL, which is used for the treatment of asthma and prevention of bronchospasm in asthma patients. As per data from […]
Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ subsidiary BL Indústria Ótica. The financial terms of the deal were not disclosed. Through the deal, MedQuímica will gain rights to the three central nervous system drugs — Limbitrol, Melleril, […]
India-based Lupin Limited said that it has obtained tentative approval for its abbreviated new drug application (ANDA) of Doxycycline Capsules, 40 mg from the US Food and Drug Administration (FDA). Doxycycline Capsules, 40 mg is the generic version of Oracea Capsules, 40 mg, of Galderma Laboratories. Oracea, which is a tetracycline class medicine, is used […]
Lupin Limited has secured tentative approval for its Abbreviated New Drug Application (ANDA) for Drospirenone Tablets, 4 mg from the US Food and Drug Administration (FDA). According to the Indian pharma company, Drospirenone Tablets, 4 mg is the generic version of Slynd Tablets, 4 mg of Exeltis USA. Slynd Tablets (drospirenone) is an oral contraceptive. […]
Indian pharma company Lupin Limited has launched Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg in the US. The product is the generic version of Invega Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg, of Janssen Research and Development. Invega (paliperidone), which is an atypical antipsychotic, which has […]
Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, from Sunovion Pharmaceuticals for $75 million. The Indian pharma company anticipates the deal to be incremental to earnings in the first year. According to Lupin, the acquisition of […]